Watch Converting IV-drip Medications into Shots - Bloomberg

Jan 16th, 2025

Converting IV-drip Medications into Shots

Biopharma company Halozyme Therapeutics is on a mission to replace IV-drug delivery. It develops subcutaneous devices to make it easier and quicker to inject high-volume drugs into patients. Halozyme Therapeutics CEO Helen Torley joined Bloomberg Open Interest to talk about the technology and gives her outlook on pharma M&A.

Top Video

Duration:2:50

BlackRock's Rieder Says Equities Aren't in a Bubble, Fed on Hold

Duration:1:48

Trump’s Latest 10% Global Tariffs Ruled Unlawful by US Trade Court

Duration:1:53

Jobs Report Locks in Fed Stalemate, PGIM's Collins Says

Surveillance

Duration:46:40

Scaramucci: My Buddies Regret Picking Trump

Duration:2:03

US Jobs Data ‘Steady as It Goes,’ Says BlackRock’s Rosenberg

Duration:1:12

SoftBank Cuts Target for OpenAI Margin Loan

Duration:1:34

Earnings Resilience Amid Iran Risk: Markets Snapshot

The Opening Trade

Duration:3:32

Starmer Faces Heavy Losses in Local Election

The Opening Trade

Duration:5:01

Oil Market Completely Broken, Vanda Insights Says

Duration:8:46

Commerzbank Steps Up UniCredit Defense

The Opening Trade

Duration:2:02

Wayve CEO on Tesla, Waymo, Future of Self-Driving Cars

Duration:4:10

China's Growing Anxiety Over Iran

Available on:

Listen onApple TV Listen onRoku Listen onSamsung TV Listen onFire TV Listen onAndroid TV Listen onRakuten TV Listen onHaystack News

Watch BTV in your area: